Aspirin Prodrugs

Shengmin Sang of NCA&T Wins Innovation for Impact Grand Prize

March 30, 2017

By Barry Teater, NCBiotech Writer. Research to prevent colon cancer by pairing the classic wonder drug aspirin with an active ingredient in ginger has earned a Greensboro scientist a statewide honor that carries an $11,000 reward. Shengmin Sang, Ph.D., associate professor with the North Carolina Agricultural and Technical State University in Greensboro,was awarded the inaugural Innovation […]

NCA&T’s Shengmin Sang Reaping Research Rewards

March 30, 2017

By Mindy Hamlin, NCBiotech Writer. Read the original article on the NC Biotech Center website. It has been a good run lately for Shengmin Sang, Ph.D. Sang, associate professor and lead scientist in the Center for Excellence in Post-Harvest Technologies ​at North Carolina Agricultural and Technical State University labs in Kannapolis, was awarded the inaugural […]

Shengmin Sang Leading NC A&T to Front of Fight on Cancer

August 03, 2016

Read the original article on Diverse Issues in Higher Education. A prolific scholar and 2015 winner of the Research Article of the Year award from the Journal of Agricultural and Food Chemistry, Dr. Shengmin Sang is helping to position historically Black North Carolina A&T State University (N.C. A&T) into a center of cutting-edge cancer research. […]

Novel Resveratrol-based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity

July 23, 2015

Novel Resveratrol-based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity, J Med Chem. 2015 J Zhu Y, Fu J, Shurlknight K, Soroka D, Hu Y, Chen XL, Sang S. Abstract Regular aspirin use has been convincingly shown to reduce the risk of colorectal cancer. However, long-term use of aspirin leads to gastrotoxicity. Herein, we designed and synthesized […]